The biological functions of the versatile transcription factors STAT3 and STAT5 and new strategies for their targeted inhibition

被引:78
作者
Desrivieres, Sylvane
Kunz, Christian
Barash, Itamar
Vafaizadeh, Vida
Borghouts, Corina
Groner, Bernd
机构
[1] Inst Biomed Res, D-60569 Frankfurt, Germany
[2] Agr Res Org, Volcani Ctr, Inst Anim Sci, IL-50250 Bet Dagan, Israel
关键词
STAT; signal transduction; mammary gland; cancer therapy; peptide aptamers; RNA interference;
D O I
10.1007/s10911-006-9014-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Signal transducers and activators of transcription (STATs) comprise a unique family of transcription factors, which transmit the interactions of cytokines, hormones and growth factors with their cell surface receptors into transcriptional programs. The mechanism of STAT activation has been well-established and comprises tyrosine phosphorylation, dimerization, nuclear translocation, binding to specific DNA response elements, recruitment of coactivators or co-repressors and transcriptional induction or repression of target genes. Gene deletion, microarrays, proteomics and chromatin immunoprecipitation experiments have revealed target genes with a broad range of functions regulated by STAT3 and STAT5. In the mammary gland, STAT5-induced genes contribute mainly to the prolactin dependent lobulo-alveolar development, whereas STAT3 induced genes control apoptosis during involution. Crucial effects have also been observed in other tissues. The germ line deletion of STAT3 or STAT5 causes early embryonal or perinatal lethality in mice. STAT5 is also required for proliferation of T- and B-cells and hematopoietic stem cell self-renewal. Deregulated STAT activity is often found associated with tumorigenesis and activated STATs seem to be limiting components in tumor cells. This review summarizes the functions of STAT3 and STAT5 in different cell types and the strategies that are used to counteract their action in tumor cells.
引用
收藏
页码:75 / 87
页数:13
相关论文
共 106 条
[1]   Inhibition of transcription factor Stat5 induces cell death of human prostate cancer cells [J].
Ahonen, TJ ;
Xie, JW ;
LeBaron, MJ ;
Zhu, JQ ;
Nurmi, M ;
Alanen, K ;
Rui, H ;
Nevalainen, MT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (29) :27287-27292
[2]   Roles of STAT3 defined by tissue-specific gene targeting [J].
Akira, S .
ONCOGENE, 2000, 19 (21) :2607-2611
[3]   The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immuneresponse [J].
Alexander, WS ;
Hilton, DJ .
ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 :503-529
[4]   Identification of GRIM-19, a novel cell death-regulatory gene induced by the interferon-β and retinoic acid combination, using a genetic approach [J].
Angell, JE ;
Lindner, DJ ;
Shapiro, PS ;
Hofmann, ER ;
Kalvakolanu, DV .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (43) :33416-33426
[5]   Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma [J].
Aoki, Y ;
Feldman, GM ;
Tosato, G .
BLOOD, 2003, 101 (04) :1535-1542
[6]  
Barton BE, 2004, MOL CANCER THER, V3, P11
[7]  
Blaskovich MA, 2003, CANCER RES, V63, P1270
[8]   IGF-2 is a mediator of prolactin-induced morphogenesis in the breast [J].
Brisken, C ;
Ayyannan, A ;
Nguyen, C ;
Heineman, A .
DEVELOPMENTAL CELL, 2002, 3 (06) :877-887
[9]   Prolactin signals via Stat5 and Oct-1 to the proximal cyclin D1 promoter [J].
Brockman, JL ;
Schuler, LA .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2005, 239 (1-2) :45-53
[10]   Sequence-specific peptide aptamers, interacting with the intracellular domain of the epidermal growth factor receptor, interfere with Stat3 activation and inhibit the growth of tumor cells [J].
Buerger, C ;
Nagel-Wolfrum, K ;
Kunz, C ;
Wittig, I ;
Butz, K ;
Hoppe-Seyler, F ;
Groner, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (39) :37610-37621